Kyoto, Japan and Marcy l'Etoile, France - 21 May 2010 - Shimadzu and bioMérieux announce...
– Newly evolved enzymes make some bacteria resistant to all common antibiotics
– Healthcare workers slow to receive flu vaccines
– Countries not doing enough to combat ‘superbugs’
About 7 million healthcare-associated infections (HAIs) in the US and Europe each year
Veyrier-du-Lac (France), 23 September 2009 – According to a meeting of over 60 infectious disease experts, the global medical community must act on three imminent threats to patients across the world. First threat: common bacteria, such as Escherichia coli (E. coli) are now producing enzymes that make the bacteria capable of de-activating all but the antibiotics that specialists reserve as a last line of defense. Second threat: healthcare workers themselves may be contributing to the spread of infections by failing to get flu vaccinations and, in some countries, coming to work when they are ill rather than taking sick days. Third threat: health ministries are failing to adopt proven health policies that could limit the spread of infections in hospitals and other healthcare establishments.
The experts, meeting at the 2nd World HAI Forum, called upon health authorities and healthcare professionals worldwide to “reduce consumption of antibiotics and act as quickly as possible before some multi-resistant bacteria become endemic”. Many of the experts expressed concern that there is a false impression that HAIs are under control. With new kinds of bacterial resistance (KPC carbapenemases) and new strains (PVL-positive Staphylococcus aureus) appearing, HAIs are still a major public health threat.
During their discussions at the Fondation Mérieux conference centre the experts proposed “the bundling of preventive actions, which have proven to be effective in several countries, to fight against Methicillin resistant Staphylococcus aureus: patient isolation, reinforced hygiene, screening and decolonisation of carriers”. In some countries more than 60% of S. aureus cases in hospital intensive care units are now resistant to first-line antibiotics.1
Another topic at the forum was influenza, which is also transmitted in hospitals and poses a risk for the most vulnerable patients, including the very young, the very old and immunocompromised patients. Citing the underestimation of this risk by healthcare professionals and their low vaccination rates, the experts are pushing for them to get vaccinated.
The participants also encouraged “local public reporting of HAIs by all hospitals in order to measure the success of prevention policies”.
“Bacteria know no borders and healthcare professionals around the world are facing the same challenges of increasingly complex and resistant microorganisms,” stated Alain Mérieux, president of bioMérieux. “By mobilising the forces of some of the world’s leading experts in infection prevention and control it is our ambition to help the global healthcare community take concrete action to address this critical public health issue.”
For Didier Pittet (director of the infection control programme, University of Geneva Hospitals and lead of the First Global Patient Safety Challenge, WHO World Alliance for Patient Safety), said: “The real global pandemic today is antibiotic resistance, which is a silent epidemic and a time-bomb because tomorrow we won’t have any effective antibiotics. Healthcare-associated infections are making this problem of resistance even worse; the world needs to wake up to this now and make fighting HAIs and the spread of resistance a priority in healthcare policies. This forum, a unique place for exchange between international experts, contributes to raising awareness about the seriousness of the situation worldwide.”
Affecting at least 7 million people per year in the US and Europe, healthcare-associated infections are now recognised as a critical public health issue and continue to be a major cause of morbidity, mortality and excess healthcare cost.2,3 Their prevalence is continually rising due to increasingly sophisticated medical treatment and surgical procedures, international travel and the overuse or misuse of broad-spectrum antibiotics.
The 2nd World HAI Forum is an initiative of bioMérieux, a world leader in the field of in vitro diagnostics. bioMérieux is a partner with healthcare providers in implementing infection control policies to screen patients, manage outbreaks and monitor epidemiology.
To further promote the exchange of scientific knowledge and the development of a global HAI network, bioMérieux has, over the past two years, organised HAI-focused symposia in countries including the United States, Belgium, the Netherlands, Portugal, Spain, China and Japan. The 3rd World HAI Forum will be held in two years.
About the World HAI Forum
The World HAI Forum brings together leading physicians and microbiologists in the field of infection control and prevention from around the world. Held biannually, the forum is a private initiative, independent from official organisations or authorities.
Its missions are to help guide and influence decision-makers by building awareness and understanding of healthcare-associated infections. At biannual meetings forum members examine current trends and data and engage in a lively scientific exchange about future challenges and actions to take, with the goal of anticipating how HAIs will evolve in the five years to come.
While most meetings focus on scientific developments retrospectively in an academic format, the World HAI Forum gives participating experts a chance to do prospective analysis of subjects that are not usually discussed. It also provides healthcare professionals with an opportunity to focus on success stories, best practices and to understand differences between countries.
- Laxminarayan, R., A. Malani. Extending the cure: policy responses to the growing threat of antibiotic resistance. Washington, D.C, Resources for the Future 2007
- Center for Disease Control and Prevention (CDC) figures 2007
- Suetens C. Healthcare associated infections in Europe: Burden and surveillance strategies, IPSE, 2006
Marcy l'Etoile (France) and Cambridge, Massachusetts (US) - 21 April 2010 - Exclusive agreement to...
Philips and bioMérieux Announce Partnership to Develop and Market Next-Generation Handheld Diagnostic Solutions for Point-of-Care
Fully automated handheld diagnostic test devices designed to improve diagnosis and disease management in critical...
Marcy l'Etoile, France, 12 November 2009 - A world leader in the field of in...